Business & regional news

Month Year

Month Year

Nov 14, 2025

Medtronic Aurora EV-ICD™ system demonstrates exceptional results at six months in the Enlighten real-world post-market study while the OmniaSecure™ defibrillation lead sustains performance at three years in the LEADR Pivotal Trial

APHRS.25: Medtronic showcases breadth of defibrillation portfolio with outcomes from extravascular and transvenous defibrillation studies for the treatment of dangerous heart rhythm episodes
- Cardiac Rhythm Management
Sep 2, 2025

Compelling data at ESC Congress 2025 reinforce safety and performance of the Medtronic OmniaSecure™ defibrillation lead, including in the left bundle branch area

The upcoming U.S. launch of the small-diameter OmniaSecure defibrillation lead will introduce the first FDA-approved lead for both adults and adolescent pediatric patients
- Cardiac Rhythm Management
Feb 6, 2025

DiVERT Stroke study uncovers sex-based disparities in post-stroke cardiac care

Women are less likely than men to receive post-stroke cardiac monitoring according to a new analysis unveiled at the International Stroke Conference 2025
- Cardiac Rhythm Management
Jan 16, 2025

Medtronic LINQ™ family of insertable cardiac monitors with AI-based algorithms accurately predicts risk thresholds for patients with atrial fibrillation

DEFINE AFib results at AF Symposium 2025: First-of-its-kind app-based study uses AF burden data to identify patients at high risk for AF-related healthcare utilization

LINQ™ insertable cardiac monitors showed 4 times greater episode sensitivity compared to Apple Watch™*
- Cardiac Rhythm Management
Sep 2, 2024

Medtronic EV ICD global pivotal trial final results demonstrate high ATP success and effective defibrillation: ESC Congress 2024
- Cardiac Rhythm Management

Show per page